Skip to main content

Table 3 Systolic and diastolic blood pressure in the KM2H2 and standard care groups at baseline, 6-month, and 30-month post intervention

From: Persistent effect at 30-month post intervention of a community-based randomized trial of KM2H2 in reducing stroke and heart attack among senior hypertensive patients

Variables/Times

KM2H2

Control

p value

Crude Mean (SD)

Adjusted Mean [95% CI]

Crude Mean (SD)

Adjusted Mean [95% CI]

 

Systolic BP

 Baseline

140.72 (17.14)

140.70 [136.72,144.69]

141.67 (17.30)

140.56 [136.67,144.44]

0.94

 6-month

136.15 (16.00)

134.82 [130,41,139.23]

138.38 (15.31)

137.26 [133.12,141.40]

0.31

 30-month

132.71 (13.69)

132.15[127.90,136.39]

136.00 (16.09)

135.17[130.90,139.43]

0.21

Diastolic BP

 Baseline

86.11 (9.32)

84.27 [81.40,87.15]

86.99 (12.26)

85.67 [82.86,88.50]

0.39

 6-month

81.19 (9.17)

79.03 [75.92,82.13]

84.50 (10.03)

83.40 [80.44,86.36]

0.11

 30-month

80.28 (8.69)

78.22 [75.21,81.23]

81.82 (8.56)

79.82 [76.80,82.83]

0.37

  1. Note: SD standard error, CI confidence interval, BP blood pressure. The adjusted mean were estimated and compared by using mixed effects model controlling for the effect of cluster randomization, repeated measures, baseline difference, and covariates